J Clin Med. 2025 Apr 25;14(9):2967. doi: 10.3390/jcm14092967.
ABSTRACT
Objective: To evaluate the outcomes of a preliminary single-center experience with Robotic Roux-en-Y Gastric Bypass (R-RYGB) using the Hugo™ Robotic-assisted Surgery system, focusing on operative time, perioperative complications, and length of hospital stay. Methods: A retrospective review identified 19 consecutive patients who underwent R-RYGB with the Hugo™ system between January 2023 and January 2024. The baseline data collected were sex, age, and BMI. Key outcomes measured were operative time, docking time, length of hospital stay, conversions to open or laparoscopic surgery, reinterventions, readmissions, and intraoperative and early (<30 days) postoperative complications (bleeding, leak, and stenosis). Results: Nineteen patients underwent R-RYGB using the Hugo™ system. The mean age was 43.5 ± 10 years, and the mean BMI was 39.4 ± 2.9 kg/m2. Among these patients, 11 were female (57.9%); 3 had diabetes mellitus (15.8%), 3 had obstructive sleep apnea syndrome (15.8%), and 7 had hypercholesterolemia (36.8%). The mean operative time was 177.8 ± 34.7 min, with a mean docking time of 12.5 ± 4.6 min. The mean length of hospital stay was 3.1 ± 0.2 days. There were no intraoperative complications, conversions, reinterventions, readmissions, or 30-day postoperative complications. All procedures were completed uneventfully. Conclusions: Our preliminary experience suggests that R-RYGB using the Hugo™ Robotic-assisted Surgery system is safe and feasible, with acceptable operative and docking times and no perioperative complications.
PMID:40363998 | DOI:10.3390/jcm14092967